Clinical trials play a large and growing role in the medical options patients have today and in the future. Nearly 4,000 experimental drug therapies are in active clinical trials today and that number will continue to grow as improvements are made in detecting disease, in understanding the root causes of acute and chronic illnesses, and in discovering medical innovations.
Clinical trials help to establish therapeutic innovations for vision threatening diseases. By participating with informed consent in clinical trials at the WVU Eye Institute, patients can receive new treatments before they become widely available to the public. In addition, because certain vision threatening diseases such as glaucoma tends to run in families, participating in clinical trials may one day benefit the children and grandchildren of participants.
The WVU Eye Institute clinical research program is directed by Tony Realini, MD, MPH.
To find out if you are eligible to participate in a clinical trial – contact Aimie Jones at firstname.lastname@example.org.
Clinical trials research opportunities include:
- Dr. Ronald Gross - Study the injection of a prostaglandin into the eye to control eye pressure vs. eye drops to control eye pressure
- Dr. Anthony Realini - St. Lucia/Dominica study to prove the effectiveness of laser as a first line of treatment for glaucoma in people of African decent
- Dr. Anthony Realini - Study on a new class of eye drops to control glaucoma
- Dr. Muge Kesen - Study of the long-term safety and efficacy of the Human Anti-TNF Monoclonal Antibody Adallimumab in subjects with Non-infectious, Intermediate, Posterior, Pan, Uvetis
- Dr. Muge Kesen - Trial to establish the safety and efficacy of intraviterous administration of Fovista (Anti-PDGF-B Pegylated Aptamer) administered in combination with either Avastin or Eylea compated to Avastin or Eylea monotherapy in subjects with subfoveal neovascular age-related Macular Degeneration
- Dr. Ghassan Ghorayeb - Study of the progression of geographic atrophy secondary to age-related Macular Degeneration
- Dr. Ghassan Ghorayeb - Study to assess the efficacy and safety of Lampalizumab administered intraviterally to patients with geographic atrophy secondary to age-related Macular Degeneration
- Dr. Ghassan Ghorayeb - Study comparing the efficacy and safety of RTH258 vs. Afibercept in subjects with neovascular age-related Macular Degeneration
- Dr. Ghassan Ghorayeb - Ocriplasmin research to better inform treatment (ORBIT)
Learn more about clinical trials in vision research here